CARPEDIEM® for continuous kidney replacement therapy in neonates and small infants: a French multicenter retrospective study
- PMID: 36625933
- DOI: 10.1007/s00467-022-05871-0
CARPEDIEM® for continuous kidney replacement therapy in neonates and small infants: a French multicenter retrospective study
Abstract
Background: The Cardio-Renal Pediatric Dialysis Emergency Machine (CA.R.P.E.D.I.E.M.®) device is a continuous kidney replacement therapy (CKRT) equipment dedicated to neonates and small infants. This study aimed to assess the effectiveness, feasibility, outcomes, and technical considerations relating to CARPEDIEM® use.
Methods: This retrospective multicenter study included 19 newborns and six infants receiving CARPEDIEM® in five French pediatric and neonatal intensive care units. Laboratory parameters were collected at the initiation and end of the first CARPEDIEM® session. Results are presented as median [IQR] (range).
Results: At initiation, age was 4 days [2-13] (1-1134) with a body weight of 3.3 kg [2.5-4] (1.3-11.1). Overall, 131 sessions and 2125 h of treatment were performed. Treatment duration per patient was 42 h [24-91] (8-557). Continuous veno-venous hemofiltration (CVVH) was performed in 20 children. Blood flow rate was 8 mL/kg/min [6-9] (3-16). The effluent flow rate for CVVH was 74 mL/kg/h [43-99] (28-125) and net ultrafiltration (UF) 6 mL/kg/h [2-8] (1-12). In the five children treated by hemodialysis, the blood and dialysate flow rates were 6 mL/kg/min [5-7] (4-7) and 600 mL/h [300-600] (120-600), respectively, while session duration was 8 h [6-12] (2-24). Most infants required a catheter between 4.5 and 6.5 French. Hemodynamic instability with a need for volume replacement occurred in 31 sessions (23%). Thrombocytopenia was observed in 29 sessions (22%). No hemorrhage occurred; all the patients survived the sessions, but only eight patients (32%) were alive at hospital discharge.
Conclusions: These data confirm that the use of CARPEDIEM® is safe and effective in critically ill neonates and infants. A higher resolution version of the Graphical abstract is available as Supplementary information.
Keywords: CARPEDIEM®; Continuous kidney replacement therapy; Neonate.
© 2023. The Author(s), under exclusive licence to International Pediatric Nephrology Association.
References
-
- Sutherland SM, Ji J, Sheikhi FH, Ling XB et al (2013) AKI in hospitalized children: epidemiology and clinical associations in a national cohort. Clin J Am Soc Nephrol 8:1661–1669. https://doi.org/10.2215/CJN.00270113 - DOI - PubMed - PMC
-
- Jetton JG, Boohaker LJ, Sethi SK, Askenazi DJ et al (2017) Incidence and outcomes of neonatal acute kidney injury (AWAKEN): a multicentre, multinational, observational cohort study. Lancet Child Adolesc Health 1:184–194. https://doi.org/10.1016/S2352-4642(17)30069-X - DOI - PubMed - PMC
-
- de Galasso L, Picca S, Guzzo I (2020) Dialysis modalities for the management of pediatric acute kidney injury. Pediatr Nephrol 35:753–765. https://doi.org/10.1007/s00467-019-04213-x - DOI - PubMed
-
- Ronco C, Brendolan A, Bragantini L, La Greca G et al (1986) Treatment of acute renal failure in newborns by continuous arterio-venous hemofiltration. Kidney Int 29:908–915. https://doi.org/10.1038/ki.1986.85 - DOI - PubMed
-
- Ronco C, Garzotto F, Brendolan A, Goldstein SL et al (2014) Continuous renal replacement therapy in neonates and small infants: development and first-in-human use of a miniaturised machine (CARPEDIEM). Lancet 383:1807–1813. https://doi.org/10.1016/S0140-6736(14)60799-6 - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
